Prevalence and Characteristics of Intimate Partner Violence Against Individuals Seeking Hematological Consultations

Intimate Partner Violence Clinical Trial

— HEMATO-WAST  

Official title:

Prevalence and Characteristics of Intimate Partner Violence Against Individuals Seeking Hematological Consultations

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06415968
• Other study ID #: NIMAO/2023-2/JCG-01
• Status: Not yet recruiting
• Start date: June 2024
• Est. completion date: June 2025

Study information

• Verified date: May 2024
• Source: Centre Hospitalier Universitaire de Nimes
• Contact: Jean-Christophe Gris
• Phone: 04.66.68.32.11
• Email: jean.christophe.gris[@]chu-nimes.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Intimate violence against individuals, which is particularly marked among women, is one of the most widespread human rights violations in the world.

The Women Abuse Screening Tool (WAST) self-questionnaire is a screening tool validated in French.

Our preliminary data describing the association between intimate violence against women and the first attack of unexplained venous thromboembolic disease, show a significant frequency of positive responses to the WAST among women attending a biological hematology consultation at the CHU de Nîmes, for reasons of hemostasis disorders (8% out of the first 200 cases).

The study authors wish to establish the prevalence of this situation among patients presenting to the CHU de Nîmes for hematological exploration and management. They hypothesize that the prevalence of violence against individuals seen in Hematology consultations is higher among individuals with hemostasis pathologies (hemorrhagic and thrombotic pathologies) than those with cellular pathologies, and higher among women than men.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 3240
• Est. completion date: June 2025
• Est. primary completion date: June 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Currently in a relationship or has been in one in the last 12 months, regardless of the length of the relationship

• Willing to complete the anonymous WAST self-questionnaire

• able to read and understand French

• Outpatient consultant at Nîmes University Hospital in one of the following departments:

• Biological hematology consultation

• Clinical hematology consultation

• Vascular medicine consultation

Exclusion Criteria:

• Individuals under court protection, guardianship or curatorship

• Individuals unable to read and understand French

• Individuals who have already completed the WAST questionnaire during the study period

• Individuals unable to get away from their partner during the consultation to complete the questionnaire in isolation

Related Conditions & MeSH terms

• Deep Vein Thrombosis (DVT)/Thrombophlebitis
• Embolism
• Embolism and Thrombosis
• Intimate Partner Violence
• Pulmonary Embolism
• Pulmonary Embolism and Thrombosis
• Thrombophlebitis
• Thrombosis
• Venous Thrombosis

Locations

Country	Name	City	State
France	CHUNimes	Nîmes

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire de Nimes

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Prevalence of patients experiencing Intimate Partner Violence according to consulting department	Percentage of patients with a Women Abuse Screening Tool (WAST) score = 5 consulting in the hemostasis pathology versus cellular hematological pathology department. The WAST is an 8-item questionnaire with a score ranging from 0 to 16 (worst violence), with a cut-off of 5 for presence of violence	Day 0
Secondary	Prevalence of Intimate Partner Violence in men versus women according to consulting department	WAST score = 5 consulting in the hemostasis pathology versus cellular hematological pathology department in women versus men	Day 0
Secondary	Prevalence of Intimate Partner Violence according to patient disease status and gender	WAST questionnaire total score in women versus men, for hemostasis disease versus cellular hematological disease versus hemorrhagic symptomatology versus thrombotic symptomatology	Day 0
Secondary	WAST questionnaire score according to patient disease status and gender	Score for individual items of WAST questionnaire in women versus men, for hemostasis disease versus cellular hematological disease versus hemorrhagic symptomatology versus thrombotic symptomatology	Day 0
Secondary	Association between the major risk factors for Intimate Partner Violence and WAST score.	WAST questionnaire total score according to: Number of years together, Violence at home growing up, Marital status (divorced or separated), Children living at home, Working status, Finances (personal income, financial difficulties), Living status (together vs separate, size of dwelling, neighbors nearby), Health status of living partner, Health status of patient	Day 0